Mesa Laboratories Inc (MLAB)

Net profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	-254,246	948	-717	1,819	930	319	-2,192	222	3,655	7,575	5,093	4,052	3,274	17,995	17,907	18,290	21,670	18,643	24,131	22,063
Revenue (ttm)	US$ in thousands	216,187	212,874	213,688	219,272	219,080	163,489	163,898	140,989	125,456	163,420	142,896	138,916	133,937	130,181	127,664	121,340	117,687	109,925	104,952	104,281
Net profit margin		-117.60%	0.45%	-0.34%	0.83%	0.42%	0.20%	-1.34%	0.16%	2.91%	4.64%	3.56%	2.92%	2.44%	13.82%	14.03%	15.07%	18.41%	16.96%	22.99%	21.16%

March 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-254,246K ÷ $216,187K
= -117.60%

Mesa Laboratories Inc's net profit margin has exhibited significant fluctuations over the past few quarters. The company experienced a negative net profit margin in the most recent quarter ending Mar 31, 2024, indicating that its expenses exceeded its revenues, resulting in a loss. This represents a concerning trend and warrants further investigation into the reasons behind the poor performance.

In contrast, the company had positive net profit margins in the preceding quarters, although there was variability in the margins. Dec 31, 2023, and Mar 31, 2021 stood out as particularly strong quarters with net profit margins of 13.82% and 18.41% respectively, indicating healthy profitability levels.

The inconsistency in Mesa Laboratories Inc's net profit margin suggests fluctuations in its operational efficiency and ability to control costs. Management should closely monitor expenses, revenue streams, and overall business performance to address the recent negative trend and strive for more consistent profitability.